arrow_back Back to App

Support for World Sickle Cell Awareness Day

The U.S. Senate expresses support for designating June 19, 2025, as World Sickle Cell Awareness Day. The aim is to increase public awareness of the disease, promote research, early detection, and access to treatment. This initiative seeks to improve the quality of life for individuals affected by the disease and their families.
Key points
Increasing awareness of sickle cell disease in the U.S. and globally.
Supporting research, early detection, and new treatment methods.
Striving for equitable access to innovative therapies for all social groups.
Calling for the elimination of barriers to treatment access within Medicare and Medicaid systems.
Encouraging the creation of educational programs and events about the disease.
article Official text account_balance Process page
Introduced
Citizen Poll
No votes cast
Additional Information
Print number: 119_SRES_292
Sponsor: Sen. Booker, Cory A. [D-NJ]
Process start date: 2025-06-18
Lustra uses Artificial Intelligence. Verify details in source documents.
Summarized by: gemini-2.5-flash
Source data: api.congress.gov
AI work logs for this document launch

OFFICIAL LEGAL TITLE

A resolution expressing support for the designation of June 19, 2025, as "World Sickle Cell Awareness Day" in order to increase public awareness across the United States and global community about sickle cell disease and the continued need for empirical research, early detection screenings, novel effective treatments leading to a cure, and preventative care programs with respect to complications from sickle cell anemia and conditions relating to sickle cell disease.

FREQUENTLY ASKED QUESTIONS

What is the official ID of this bill?

The official print number for this legislation is 119_SRES_292.

Which chamber initiated this legislation?

This legislation was initiated in the Senate.

When did the legislative process begin?

The process officially started on 2025-06-18.

What are the main provisions?

Key points include:

  • Increasing awareness of sickle cell disease in the U.S. and globally.
  • Supporting research, early detection, and new treatment methods.
  • Striving for equitable access to innovative therapies for all social groups.
  • Calling for the elimination of barriers to treatment access within Medicare and Medicaid systems.
  • Encouraging the creation of educational programs and events about the disease.
What is the specific legal status?

The current status is Introduced.

Where can I read the full text of this legislation?

The full official text is available at: View full text

Who is the primary sponsor?

The primary sponsor is Sen. Booker, Cory A. [D-NJ].

What is the latest detailed status?

The latest detailed status is: Introduced in Senate

Is this summary verified?

Yes. This content was analyzed by AI and verified by the Lustra Judge System on 2025-12-23.

CATEGORIES

Health